Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
JB.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
JB.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
A.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
A.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
A.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
A.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XDK.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XDK.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XDK.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XDK.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.58ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.58ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.58ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.58NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.1.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.1.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.1.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.1.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.2.3.6ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.2.3.6ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.2.3.6ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.2.3.6NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
GA.10.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
GA.10.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
GA.10.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
GA.10.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CP.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CP.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CP.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CP.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.39ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.39ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.39ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.39NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.40ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.40ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.40ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.40NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BN.1.3.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BN.1.3.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.1.3.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.1.3.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BM.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BM.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.57ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.57ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.57ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.57NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used